{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Germ+Cell+Tumor&page=82", "query": { "condition": "Germ Cell Tumor", "page": 82 }, "page_size": 10 }, "pagination": { "page": 82, "page_size": 10, "total_count": 5233, "total_pages": 524, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Germ+Cell+Tumor&page=83&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Germ+Cell+Tumor&page=81&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-05T04:47:02.416Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06104488", "title": "A Study of Avutometinib for People With Solid Tumor Cancers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Refractory Cancer", "CNS Tumors", "CNS Tumor, Adult", "CNS Tumor, Childhood", "MAP Kinase Family Gene Mutation", "NF1", "Plexiform Neurofibroma", "Low-grade Glioma", "Optic Pathway Gliomas", "Neuroblastoma", "Primary Brain Tumor", "Solid Tumor", "Solid Tumor, Adult", "Solid Carcinoma", "Central Nervous System Tumor" ], "interventions": [ { "name": "Avutometinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "3 Years to 30 Years" }, "enrollment_count": 3, "start_date": "2023-10-20", "completion_date": "2026-11-03", "has_results": false, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 2, "location_summary": "Atlanta, Georgia • New York, New York", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06104488" }, { "nct_id": "NCT02800486", "title": "Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glioblastoma", "Anaplastic Astrocytoma", "Anaplastic Oligoastrocytoma", "Glioma", "Brain Neoplasm", "Brain Cancer", "Brain Tumor", "Brain Tumor, Recurrent", "Brain Neoplasm, Malignant" ], "interventions": [ { "name": "Intra-arterial Cetuximab", "type": "DRUG" }, { "name": "Intra-arterial Mannitol", "type": "DRUG" }, { "name": "Hypofractionated re-irradiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2016-05", "completion_date": "2036-05", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02800486" }, { "nct_id": "NCT07831369", "title": "VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glioblastoma", "Astrocytoma, IDH-Mutant, Grade 4" ], "interventions": [ { "name": "Valproic Acid (VPA)", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "Simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Inova Health Care Services", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "98 Years", "sex": "ALL", "summary": "18 Years to 98 Years" }, "enrollment_count": 52, "start_date": "2026-09-04", "completion_date": "2030-12-30", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 1, "location_summary": "Fairfax, Virginia", "locations": [ { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07831369" }, { "nct_id": "NCT07439172", "title": "Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "High Grade Gliomas", "Glioblastoma", "Astrocytoma", "Oligodendroglioma" ], "interventions": [ { "name": "Pre-radiation temozolomide.", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Cooper Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 70, "start_date": "2026-07-13", "completion_date": "2029-09", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 1, "location_summary": "Camden, New Jersey", "locations": [ { "city": "Camden", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07439172" }, { "nct_id": "NCT00639639", "title": "Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malignant Neoplasms of Brain" ], "interventions": [ { "name": "tetanus toxoid", "type": "BIOLOGICAL" }, { "name": "therapeutic autologous dendritic cells", "type": "BIOLOGICAL" }, { "name": "therapeutic autologous lymphocytes", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Gary Archer Ph.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2006-02-06", "completion_date": "2022-06-01", "has_results": false, "last_update_posted_date": "2023-03-13", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00639639" }, { "nct_id": "NCT04837677", "title": "A Study of PRT1419 in Patients With Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Sarcoma", "Melanoma", "Lung Cancer", "Breast Cancer", "Esophageal Cancer", "Cervical Cancer", "Head and Neck Cancer" ], "interventions": [ { "name": "PRT1419", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Prelude Therapeutics Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2021-08-11", "completion_date": "2023-02-06", "has_results": false, "last_update_posted_date": "2023-03-15", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 7, "location_summary": "Denver, Colorado • Lake Mary, Florida • Sarasota, Florida + 4 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Lake Mary", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04837677" }, { "nct_id": "NCT02557854", "title": "HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rhabdomyosarcoma", "Neuroblastoma", "Sarcoma", "Sarcoma, Ewing", "Osteosarcoma", "Desmoid" ], "interventions": [ { "name": "Doxorubicin HCl liposomal injection", "type": "DRUG" }, { "name": "Philips Sonalleve MR-HIFU Hyperthermia", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Theodore Laetsch", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "40 Years", "sex": "ALL", "summary": "1 Year to 40 Years" }, "enrollment_count": 0, "start_date": "2016-12", "completion_date": "2019-03-16", "has_results": false, "last_update_posted_date": "2019-03-19", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02557854" }, { "nct_id": "NCT01659151", "title": "Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Melanoma" ], "interventions": [ { "name": "High Dose Interleukin-2 (IL-2)", "type": "DRUG" }, { "name": "ACT with TIL Infusion", "type": "PROCEDURE" }, { "name": "Vemurafenib", "type": "DRUG" }, { "name": "Lymphodepletion", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2012-08-03", "completion_date": "2025-08-19", "has_results": true, "last_update_posted_date": "2026-02-20", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01659151" }, { "nct_id": "NCT01473901", "title": "A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Glioblastoma" ], "interventions": [ { "name": "BKM120 + temozolomide", "type": "DRUG" }, { "name": "BKM120 +temozolomide with/without radiotherapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38, "start_date": "2011-12-30", "completion_date": "2017-05-17", "has_results": false, "last_update_posted_date": "2020-12-09", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 3, "location_summary": "Fayetteville, Arkansas • Boston, Massachusetts • Houston, Texas", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01473901" }, { "nct_id": "NCT01885767", "title": "The NF Registry Sponsored by the Children's Tumor Foundation", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neurofibromatosis 1", "Neurofibromatosis 2", "Schwannomatosis", "NF2-related Schwannomatosis" ], "interventions": [], "intervention_types": [], "sponsor": "The Children's Tumor Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 20000, "start_date": "2012-06", "completion_date": "2050-06", "has_results": false, "last_update_posted_date": "2026-10-22", "last_synced_at": "2026-11-05T04:47:02.416Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01885767" } ] }